2020 Mo-99 International Symposium

April 26-30, 2020 — Prague, Czechia


  • NNSA’s 2020 Mo-99 International Symposium
    Organized by Argonne National Laboratory, the symposium will take place in Prague, Czechia from April 26-30, 2020.
    Details…

  • Hotel
    The meeting will be at the Intercontinental Prague located in Prague, Czechia.
    Details…

  • Location
    of the meeting will be Prague, Czechia. 
    Details…

  • Register
    For more information visit:
    Online registration…

  • Visa
    Entry and exit requirements for Czechia.
    Details…

  • Organizers
    Find contact information
    Contact...

Building a Global Partnership to Supply Medical Isotopes
without the use of Highly Enriched Uranium

The U.S. Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) is pleased to announce that it will host a Molybdenum-99 (Mo-99) International Symposium in Prague, Czechia at the InterContinental Prague Hotel from April 26-30, 2020. The symposium will highlight global progress being made towards eliminating highly enriched uranium (HEU) from medical isotope production, showcase global non-HEU Mo-99 production technologies and provide a technical and policy forum for discussion of Mo-99 industry and supply issues. 

The five-day event is being organized by the Department of Energy’s Argonne National Laboratory in cooperation with the International Atomic Energy Agency, and will include oral presentations of technical and policy papers, a poster session and a technical tour of Research Reactor LVR-15, which provides irradiation services for Mo-99 producers. More information regarding DOE/NNSA’s Mo-99 program can be found here.

NNSA invites interested stakeholders to register for this event and to submit an abstract for oral or poster presentation at the symposium in one of the following Mo-99-related topical areas:

  • International HEU Minimization and Conversion
  • Establishing Mo-99 Supplies in North America and Abroad
  • Regulatory Challenges and Lessons Learned
  • Full Cost Recovery Challenges and Lessons Learned
  • The End-User Perspective (Healthcare Organizations and Radiopharmacies)
  • The Clinical Perspective of Mo-99 and Tc-99m-based Radiopharmaceuticals
  • The Mo-99 Target Residue Waste Challenge
  • Bringing Mo-99 to Market: Lessons Learned
  • Security of Supply
  • Fission and Neutron Capture Production Technology Advances
  • Accelerator Production Technology Advances
  • Emerging Production Technologies and Capabilities

Please utilize the links provided along the left margin of this web page to learn more about the venue, schedule for submitting an abstract for oral or poster session information, technical tour and how to participate in the 2020 Mo-99 International Symposium.

Questions?

For some background information about the meetings, see Mo-99 Topical Meetings Overview. For further information and questions about the 2020 Mo-99 International Symposium please contact the Organizing Committee.

2020 Mo-99 International Symposium

Mo-99 2020 News:

Nov. 26, 2019  Mo-99 2020 International Symposium Announced: View Announcement »

 

For more information:

Technical Questions:
For further information and questions please contact:

John Holland
Argonne National Laboratory

Administrative Questions:
Mrs. Karen Grudzinski
Argonne National Laboratory
9700 South Cass Avenue, Building 208
Lemont, Illinois 60439-4815, U.S.A.
Phone: +1 (630) 252-1671
Fax: +1 (630) 252-5161

HOST

NNSA logo

ORGANIZER

Argonne logo

HOST: NNSA logo ORGANIZER: Argonne logo